<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Prev Med</journal-id><journal-id journal-id-type="iso-abbrev">Prev Med</journal-id><journal-id journal-id-type="pmc-domain-id">2530</journal-id><journal-id journal-id-type="pmc-domain">hhspa</journal-id><journal-title-group><journal-title>Preventive medicine</journal-title></journal-title-group><issn pub-type="ppub">0091-7435</issn><issn pub-type="epub">1096-0260</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>HHS Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10062528</article-id><article-id pub-id-type="pmcid-ver">PMC10062528.1</article-id><article-id pub-id-type="pmcaid">10062528</article-id><article-id pub-id-type="pmcaiid">10062528</article-id><article-id pub-id-type="manuscript-id">NIHMS1885189</article-id><article-id pub-id-type="pmid">36370891</article-id><article-id pub-id-type="doi">10.1016/j.ypmed.2022.107345</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1885189</article-id><article-id pub-id-type="manuscript-id-alternative">HHSPA1885189</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Total Cost of Care associated with Opioid Use Disorder Treatment</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Toseef</surname><given-names initials="MU">Mohammad Usama</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Durfee</surname><given-names initials="J">Josh</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Podewils</surname><given-names initials="LJ">Laura Jean</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Blum</surname><given-names initials="J">Joshua</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>McEwen</surname><given-names initials="D">Dean</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hanratty</surname><given-names initials="R">Rebecca</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Everhart</surname><given-names initials="R">Rachel</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="A4" ref-type="aff">d</xref></contrib></contrib-group><aff id="A1"><label>a</label>Denver Health and Hospital Authority, Denver, Colorado</aff><aff id="A2"><label>b</label>Beaumont Research Institute, Beaumont Health, Royal Oak</aff><aff id="A3"><label>c</label>Colorado School of Public Health, University of Colorado, Denver, Colorado</aff><aff id="A4"><label>d</label>University of Colorado School of Medicine, Aurora, Colorado</aff><author-notes><corresp id="CR1">Corresponding Author: Mohammad Usama Toseef, Address: 601 Broadway, Denver, 80203 CO USA, <email>mohammadusama.toseef@beaumont.org</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>10</day><month>11</month><year>2022</year></pub-date><volume>166</volume><issue-id pub-id-type="pmc-issue-id">432360</issue-id><fpage>107345</fpage><lpage>107345</lpage><pub-history><event event-type="nihms-submitted"><date><day>24</day><month>03</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 05:25:25.783"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1885189.pdf"/><abstract id="ABS1"><p id="P1">The opioid epidemic in the United States disproportionately affects Medicaid beneficiaries than other groups. This results in a significant financial burden on state Medicaid programs. In this analysis, we investigate the association of medication for opioid use disorder (MOUD) treatment initiation and linkage to ongoing care on overall healthcare costs of Medicaid Fee-for-Service patients. We conducted a retrospective study among adult patients diagnosed with opioid use disorder (OUD) and who had a clinical encounter at a safety-net institution in Denver Colorado in 2020. Three categories of MOUD status of patients were defined: 1) identified with OUD but did not receive MOUD; 2) initiated MOUD but not linked to ongoing treatment and 3) received MOUD and linked to ongoing treatment. Our outcome variable was per-member per-month total healthcare cost. We estimated a multivariable model to test the association between healthcare cost and MOUD status, while controlling for demographic and risk classification variables. We found that in individuals with OUD who initiated MOUD treatment but were not linked to ongoing care had the highest healthcare cost, while those who were linked to ongoing MOUD treatment had the lowest healthcare cost. MOUD treatment is not only effective at addressing the significant morbidity and mortality burden of OUD but also associated with decreased financial cost, which is disproportionately incurred by Medicaid. Additional policy and care delivery changes are needed to focus efforts to improve linkage to ongoing treatment.</p></abstract><kwd-group><kwd>Medication for Opioid Use Disorder</kwd><kwd>Healthcare Cost</kwd><kwd>Medicaid</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>